Search Results - "Herrero Muñoz, N"

4CPS-080 Optimisation of antiretroviral therapy: results after simplification to bitherapy with dolutegravir/lamivudine or dolutegravir/rilpivirine by Canalejo Fuentes, MJ, Herrero Muñoz, N, Ontañón Nasarre, A, García Gil, M

“…Background and ImportanceSimplification of antiretroviral therapy with dolutegravir/lamivudine (DTG/3TC) or dolutegravir/rilpivirine (DTG/RPV) improves the…”
Get full text

1ISG-010 Pharmacy staff satisfaction and opinion of new website application for outpatient care by Merino, A, Herrero Muñoz, N, Fernández Román, AB, Hernández Muniesa, B, Pou Alonso, A, Ontañón Nasarre, A, Pedreira Bouzas, J, Canalejo Fuentes, MJ, García Gil, M

“…Background and ImportanceUp until March 2022, medical prescription orders and next appointments were printed on paper for pharmaceutical validation and…”
Get full text

4CPS-045 Healthcare evaluation of hospital pharmacy services by patients with immune-mediated inflammatory diseases: a multicentre study by Calvo García, A, Escudero Vilaplana, V, Ramirez Herraiz, E, Hernandez Muniesa, B, Pacheco Garcia-Valdecasas, M Fernández, Romero Jiménez, R, Chamorro De Vega, E, Herrero Muñoz, N, Ubeda Ruiz, B, Morell Baladron, A

“…Background and importanceImmune-mediated inflammatory diseases (IMIDs) are a group of disabling chronic diseases.Aim and objectivesTo assess the satisfaction…”
Get full text

1ISG-019 A cost-effectiveness analysis of biological therapies for moderate to severe psoriasis by Rosado, A Andres, Román, AB Fernández, Muñoz, N Herrero, Gil, M García

“…BackgroundBiological therapies (BT) have been a breakthrough in the treatment of psoriasis. Compared to conventional therapies, biologics are more effective…”
Get full text

4CPS-090 Health outcomes using direct-acting antiviral drugs for the treatment of patients with hepatitis C virus and F0–F1 liver fibrosis stage by Martín López, M, Hernández Muniesa, B, Ontañón Nasarre, A, Pou Alonso, A, Herrero Muñoz, N, García Gil, M

“…BackgroundIn clinical trials, direct-acting antiviral (DAA) drugs stop hepatitis C virus (HCV) proliferation with efficacy rates near 100% in F0–F1…”
Get full text

4CPS-219 Analysis of pharmaceutical interventions in an emergency department by Fernandez Roman, AB, Mariño Martinez, C, Martin Lopez, M, Herrero Muñoz, N, Garcia Gutierrez, MDM, Garcia Gil, M

“…BackgroundMedication errors in the emergency department can persist throughout the episode of care and up to hospital discharge, leading to inadequate…”
Get full text

1ISG-005 A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous non-small-cell lung cancer in second line in a healthcare setting by Román, AB Fernández, Lázaro, C Bravo, Fernández, J Letellez, Muñoz, N Herrero, Rosado, A Andrés, Lopez, C Mayo, Gutierrez, MDM Garcia, Gil, M Garcia

“…BackgroundNivolumab (NIV) is a monoclonal antibody for patients with pre-treated advanced nonsquamous non–small-cell lung cancer (NSCLC). It is necessary to…”
Get full text

4CPS-155 Comparative study for evaluation of the pain, ease of use and preference between two adalimumab administration devices: study adap2017 by Muñoz, N Herrero, Rosado, A Andrés, Muniesa, B Hernández, Lázaro, C Bravo, Román, AB Fernández, Alonso, A Pou, Nasarre, A Ontañón, Gutiérrez, MDM García, López, C Mayo, Gil, M García

“…BackgroundAdalimumab is a monoclonal antibody indicated in immunomediate inflammatory diseases for subcutaneous administration by two different devices:…”
Get full text

DI-095 Possible severe eosinophilia induced by dimethyl fumarate in relapsing remitting multiple sclerosis by Román, AB Fernández, Nasarre, A Ontañón, Alonso, A Pou, Rosado, A Andrés, López, C Mayo, Muñoz, N Herrero, Gomez, F, Gil, M García

“…BackgroundDimethyl fumarate (DMF) is prescribed for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS). Although mild to…”
Get full text

PS-059 Aripiprazole induced dysphagia: A case report by Rosado, A Andres, Clemente, Y Castellanos, López, C Mayo, Román, AB Fernández, Muñoz, N Herrero, Gil, M Garcia

“…BackgroundDysphagia is an uncommon adverse reaction caused by psychotropic drugs. It is a principal manifestation of extrapyramidal symptoms and the main…”
Get full text

Adherencia al tratamiento en pacientes con esclerosis múltiple: factores de riesgo by Rodríguez de Antonio, L.A., Fernández de Córdoba-García, R., Herrero-Muñoz, N., Ontañón-Nasarre, A., García-Castañón, I.

Get full text